Catalyst4, Inc.'s Form 4 filing
MapLight Therapeutics, Inc. (MPLT) · filed Oct 29, 2025
- Accession no.
- 0001900201-25-000008
- Filed
- Oct 29, 2025
- Trade date
- Oct 28, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 6 derivative transactions. Open-market purchases total $92.5M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Catalyst4, Inc.CIK 0001900201 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Voting Common Stock | CConversionAcquired | +14,256,288 | –F1 | – | 14,256,288 | Indirect | |
| Oct 28, 2025 | Voting Common Stock | PPurchaseAcquired | +5,441,176 | $17.00 | +$92,499,992 | 19,697,464 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | Voting Common Stock | CConversionDisposed | −148,809 | –F3 | – | 0 | Indirect | |
| Oct 28, 2025 | Voting Common Stock | CConversionDisposed | −444,846 | –F4 | – | 0 | Indirect | |
| Oct 28, 2025 | Voting Common Stock | CConversionDisposed | −1,263,768 | –F5 | – | 0 | Indirect | |
| Oct 28, 2025 | Voting Common Stock | CConversionDisposed | −275,148 | –F6 | – | 0 | Indirect | |
| Oct 28, 2025 | Voting Common Stock | CConversionDisposed | −5,444,807 | –F7 | – | 0 | Indirect | |
| Oct 28, 2025 | Voting Common Stock | CConversionDisposed | −6,678,910 | –F8 | – | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The Series A, A-1, B, B-1, C and D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Referenced by the price of 1 transaction in Table I.
- F3
The Series A Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Referenced by the price of 1 transaction in Table II.
- F4
The Series A-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Referenced by the price of 1 transaction in Table II.
- F5
The Series B Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.
Referenced by the price of 1 transaction in Table II.
- F6
The Series B-1 Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Referenced by the price of 1 transaction in Table II.
- F7
The Series C Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Referenced by the price of 1 transaction in Table II.
- F8
The Series D Preferred Stock automatically converted into voting common stock upon the closing of the Issuer's initial public offering for no additional consideration, on a 1-for-16.8 basis, and had no expiration date.
Referenced by the price of 1 transaction in Table II.